Log In
Print
BCIQ
Print
Print this Print this
 

Cu-64-TP3805 (NVB-64)

  Manage Alerts
Collapse Summary General Information
Company NuView Life Sciences Inc.
DescriptionAdenylate cyclase activating polypeptide pituitary (ADCYAP1; PACAP) analog TP3805 labeled with Cu-64
Molecular Target Vasoactive intestinal peptide receptor 1 (VPAC1)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect malignant breast tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today